Evidence map›Paper›PMID 24920933›Full record

ArticleClinical, cosmetic and investigational dermatology2014

Predictability of the individual clinical outcome of extracorporeal shock wave therapy for cellulite.

Kai-Uwe Schlaudraff, Maren C Kiessling, Nikolaus Bm Császár, Christoph Schmitz

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03275259 (Effect of Extracorporeal Shock Wave Therapy in the Treatment of Gynoid Lipodystrophy and Localized Fat), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03275259 nacompletednot on this mapstarted 2017, after this paper: background citation

Effect of Extracorporeal Shock Wave Therapy in the Treatment of Gynoid Lipodystrophy and Localized Fat

TypeinterventionalSponsorIndústria Brasileira Equipamentos Médicos - IBRAMEDRan2017 to 2018Enrolled30ConditionsLipodystrophy, Cellulitis, AdiposityArmsTHORK Shock Wave® (Extracorporeal shock waves)
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Cellulite: Current Understanding and Treatment.Aesthetic surgery journal. Open forum · 2023
    Review
  3. Article
  4. Article
  5. Insights Into the Pathophysiology of Cellulite: A Review.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2020
    Review
  6. Treatment for cellulite.International journal of women's dermatology · 2019
    Review
  7. Treatment of Dimpling from Cellulite.Plastic and reconstructive surgery. Global open · 2018
    Article
  8. Cellulite: a review with a focus on subcision.Clinical, cosmetic and investigational dermatology · 2017
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Kai-Uwe SchlaudraffConcept Clinic, Geneva, Switzerland.
Maren C KiesslingDepartment of Anatomy II, Ludwig-Maximilians-University of Munich, Munich, Germany.
Nikolaus Bm CsászárDepartment of Anatomy II, Ludwig-Maximilians-University of Munich, Munich, Germany.
Christoph SchmitzDepartment of Anatomy II, Ludwig-Maximilians-University of Munich, Munich, Germany.
Ludwig-Maximilians-Universität München · DEConcept Foundation · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtracorporeal shock wave therapy has been successfully introduced for the treatment of cellulite in recent years. However, it is still unknown whether the individual clinical outcome of cellulite treatment with extracorporeal shock wave therapy can be predicted by the patient's individual cellulite grade at baseline, individual patient age, body mass index (BMI), weight, and/or height.

methodsFourteen Caucasian females with cellulite were enrolled in a prospective, single-center, randomized, open-label Phase II study. The mean (± standard error of the mean) cellulite grade at baseline was 2.5±0.09 and mean BMI was 22.8±1.17. All patients were treated with radial extracorporeal shock waves using the Swiss DolorClast(®) device (Electro Medical Systems, S.A., Nyon, Switzerland). Patients were treated unilaterally with 2 weekly treatments for 4 weeks on a randomly selected side (left or right), totaling eight treatments on the selected side. Treatment was performed at 3.5-4.0 bar, with 15,000 impulses per session applied at 15 Hz. Impulses were homogeneously distributed over the posterior thigh and buttock area (resulting in 7,500 impulses per area). Treatment success was evaluated after the last treatment and 4 weeks later by clinical examination, photographic documentation, contact thermography, and patient satisfaction questionnaires.

resultsThe mean cellulite grade improved from 2.5±0.09 at baseline to 1.57±0.18 after the last treatment (ie, mean δ-1 was 0.93 cellulite grades) and 1.68±0.16 at follow-up (ie, mean δ-2 was 0.82 cellulite grades). Compared with baseline, no patient's condition worsened, the treatment was well tolerated, and no unwanted side effects were observed. No statistically significant (ie, P<0.05) correlation was found between individual values for δ-1 and δ-2 and cellulite grade at baseline, BMI, weight, height, or age.

conclusionRadial shock wave therapy is a safe and effective treatment option for cellulite. The individual clinical outcome cannot be predicted by the patient's individual cellulite grade at baseline, BMI, weight, height, or age.

Indexed as

acoustic wave therapyAWTEPATextracorporeal pulse activation therapyradial shock wave therapyRSWT

Identifiers

PMID24920933
PMCPMC4043818
OpenAlexW2116193246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.